BOLD Boundless Bio, Inc. - Common Stock
$2,92
Prix · Aoû 19, 2026
Données fondamentales au Aoû 7, 2026
Fourchette 52 semaines
$1–$3
97% of range
Note des analystes
HOLD
6 analysts
Objectif de cours
$4
+37% upside
P/E (TTM)
-1.1
ROE
-46.7%
Marge nette
—
À propos de Boundless Bio, Inc. - Common Stock Présentation de l'entreprise depuis Wikipedia
BOLD Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$2.92
Capitalisation Boursière
$65M
P/E (TTM)
-1.1
BPA (TTM)
$-2.60
Revenus (TTM)
—
Rendement div.
—
ROE
-46.7%
Dette/Capitaux propres
—
Fourchette 52 semaines
$1 – $3
BOLD Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
—
BPA
$-2.60
2023-12-31
→
2025-12-31
Flux de trésorerie libre
$-47M
2024-12-31
→
2025-12-31
Marges
—
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
BOLD
Médiane des pairs
P/E (TTM)
-1.1
—
P/B
0.7
1.6
Price / FCF (Cours / FCF)
-1.4
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
BOLD
Médiane des pairs
ROA
-32.0%
-64.3%
ROE
-46.7%
-102.1%
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
BOLD
Médiane des pairs
Current Ratio (Ratio de liquidité)
8.7
4.8
Quick Ratio (Ratio de liquidité réduite)
8.6
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
BOLD
Médiane des pairs
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
BOLD
Médiane des pairs
BOLD Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
VENTE
6 analystes
- Achat fort 0 0,0%
- Achat 0 0,0%
- Conserver 3 50,0%
- Vente 1 16,7%
- Vente forte 2 33,3%
Objectif de cours à 12 mois
1 analystes · 2026-08-19
Bas
$4.00
Haut
$4.00
Objectif médian
$4.00
+37,2%
Objectif moyen
$4.00
+37,2%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
-0.07%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $-1.06 | $-0.59 | -0.47% |
| 31 mars 2026 | $-0.60 | $-0.59 | -0.01% |
| 31 décembre 2025 | $-0.58 | $-0.53 | -0.05% |
| 30 septembre 2025 | $-0.62 | $-0.59 | -0.03% |
| 30 juin 2025 | $-0.70 | $-0.66 | -0.04% |
| 31 mars 2025 | $-0.71 | $-0.75 | 0.04% |
| 31 décembre 2024 | $-0.74 | $-0.78 | 0.04% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| BOLD | $27M | -0.5 | — | — | -46.7% | — |
| MNOV | $64M | -5.5 | — | -2928.8% | -27.1% | — |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | — |
| RNTX | — | -0.6 | — | — | — | — |
| TENX | $114M | -9.1 | — | — | -52.5% | — |
| INMB | $41M | -0.8 | 257.1% | -91866.0% | -175.3% | — |
| INKT | — | -3.8 | 4.5% | -6931.8% | 63.4% | — |
| HRTX | $245M | -10.8 | 7.4% | -13.0% | 312.5% | 73.3% |
| RNXT | — | -2.6 | 2511.6% | — | — | — |
| EXOZ | $92M | -10.0 | — | — | -172.3% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 13
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $45M | $55M | $43M | |
| SG&A Expense | $19M | $18M | $12M | |
| Operating Expenses | $64M | $73M | $55M | |
| Operating Income | $-64M | $-73M | $-55M | |
| Interest Income | $5M | $8M | $5M | |
| Other Non-op | $-2.0K | $12.0K | $80.0K | |
| Income Tax | $0 | $0 | · | |
| Net Income | $-58M | $-65M | $-49M | |
| EPS (Basic) | $-2.60 | $-3.85 | $-40.65 | |
| EPS (Diluted) | $-2.60 | $-3.85 | $-40.65 | |
| Shares (Basic) | 22,360,000 | 16,984,000 | 1,216,000 | |
| Shares (Diluted) | 22,360,000 | 16,984,000 | 1,216,000 | |
| EBITDA | $-62M | $-72M | · |
Bilan 19
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $18M | $27M | $24M | |
| Short-term Investments | $90M | $126M | $97M | |
| Prepaid Expense | $2M | $2M | $3M | |
| Current Assets | $110M | $154M | $124M | |
| PP&E (Net) | $3M | $4M | $3M | |
| PP&E (Gross) | $8M | $8M | $5M | |
| Accum. Depreciation | $5M | $4M | $3M | |
| Total Assets | $157M | $206M | $130M | |
| Accounts Payable | $1M | $1M | $2M | |
| Current Liabilities | $13M | $8M | $9M | |
| Capital Leases | $46M | $48M | · | |
| Total Liabilities | $58M | $56M | $9M | |
| Common Stock | $2.0K | $2.0K | $0 | |
| Paid-in Capital | $358M | $352M | $9M | |
| Retained Earnings | $-260M | $-201M | $-136M | |
| AOCI | $64.0K | $121.0K | $40.0K | |
| Stockholders' Equity | $99M | $151M | $-127M | |
| Liabilities + Equity | $157M | $206M | $130M | |
| Shares Outstanding | 22,407,000 | 22,300,000 | 1,248 |
Flux de trésorerie 10
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $1M | $1M | $957.0K | |
| Stock-based Comp | $6M | $8M | $3M | |
| Deferred Tax | $0 | · | · | |
| Other Non-cash | $4M | $-4M | · | |
| Operating Cash Flow | $-47M | $-61M | $-47M | |
| CapEx | $546.0K | $3M | $633.0K | |
| Investing Cash Flow | $38M | $-26M | $-38M | |
| Financing Cash Flow | $141.0K | $90M | $98M | |
| Net Change in Cash | $-9M | $3M | $13M | |
| Free Cash Flow | $-47M | $-63M | · |
Rentabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -32.0% | -38.9% | · | |
| ROE | -46.7% | -554.9% | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 8.7 | 19.0 | · | |
| Quick Ratio | 8.6 | 18.7 | · |
Valorisation (TTM) 8
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-58M | $-65M | · | |
| Market Cap | $27M | $64.7K | · | |
| P/E | -0.5 | -0.8 | · | |
| P/B | 0.3 | 0.0 | · | |
| P / Tangible Book | 0.3 | 0.0 | · | |
| P / Cash Flow | -0.6 | -0.0 | · | |
| P / FCF | -0.6 | -0.0 | · | |
| Earnings Yield | -216.7% | -132.8% | · |
Compte de résultat 12
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $14M | $10M | $10M | $11M | $12M | $12M | $13M | $14M | $15M | $13M | $10M | |
| SG&A Expense | $10M | $5M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $4M | $3M | |
| Operating Expenses | $24M | $14M | $14M | $15M | $17M | $17M | $18M | $19M | $19M | $17M | $14M | |
| Operating Income | $-24M | $-14M | $-14M | $-15M | $-17M | $-17M | $-18M | $-19M | $-19M | $-17M | $-14M | |
| Interest Income | $690.0K | $920.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $2M | |
| Other Non-op | $1.0K | · | $0 | $0 | $0 | $-2.0K | $-85.0K | $32.0K | $33.0K | $32.0K | $64.0K | |
| Net Income | $-24M | $-14M | $-13M | $-14M | $-16M | $-16M | $-16M | $-17M | $-17M | $-15M | $-12M | |
| EPS (Basic) | $-1.06 | $-0.60 | $-0.57 | $-0.62 | $-0.70 | $-0.71 | $9.93 | $-0.74 | $-0.77 | $-12.27 | $-9.75 | |
| EPS (Diluted) | $-1.06 | $-0.60 | $-0.57 | $-0.62 | $-0.70 | $-0.71 | $9.93 | $-0.74 | $-0.77 | $-12.27 | $-9.75 | |
| Shares (Basic) | 22,450,000 | 22,407,000 | -44,682,000 | 22,386,000 | 22,356,000 | 22,300,000 | -28,551,000 | 22,254,000 | 22,023,000 | 1,258,000 | -2,403,000 | |
| Shares (Diluted) | 22,450,000 | 22,407,000 | -44,682,000 | 22,386,000 | 22,356,000 | 22,300,000 | -28,551,000 | 22,254,000 | 22,023,000 | 1,258,000 | -2,403,000 | |
| EBITDA | $-24M | $-14M | · | $-15M | $-17M | $-17M | · | $-19M | $-19M | $-17M | · |
Bilan 19
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $17M | $18M | $15M | $15M | $15M | $27M | $40M | $31M | $25M | $24M | |
| Short-term Investments | $52M | $75M | $90M | $103M | $112M | $123M | $126M | $127M | $148M | $80M | $97M | |
| Prepaid Expense | $1M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $4M | $7M | $3M | |
| Current Assets | $74M | $95M | $110M | $120M | $130M | $140M | $154M | $170M | $183M | $112M | $124M | |
| PP&E (Net) | $97.0K | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $2M | $3M | |
| PP&E (Gross) | $4M | $8M | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $5M | $5M | |
| Accum. Depreciation | $3M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | |
| Total Assets | $74M | $141M | $157M | $169M | $179M | $191M | $206M | $175M | $188M | $117M | $130M | |
| Accounts Payable | $1M | $2M | $1M | $1M | $2M | $1M | $1M | $3M | $2M | $3M | $2M | |
| Current Liabilities | $8M | $10M | $13M | $12M | $9M | $6M | $8M | $10M | $9M | $11M | $9M | |
| Capital Leases | $0 | $45M | $46M | $47M | $48M | $48M | $48M | · | · | · | · | |
| Total Liabilities | $8M | $55M | $58M | $59M | $57M | $55M | $56M | · | · | · | $9M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $0 | $0 | |
| Paid-in Capital | $363M | $360M | $358M | $357M | $356M | $354M | $352M | $350M | $348M | $10M | $9M | |
| Retained Earnings | $-297M | $-273M | $-260M | $-247M | $-233M | $-217M | $-201M | $-185M | $-169M | $-152M | $-136M | |
| AOCI | $-32.0K | $-23.0K | $64.0K | $50.0K | $-4.0K | $32.0K | $121.0K | $236.0K | $-64.0K | $-21.0K | $40.0K | |
| Stockholders' Equity | $66M | $86M | $99M | $110M | $123M | $137M | $151M | $165M | $179M | $-141M | $-127M | |
| Liabilities + Equity | $74M | $141M | $157M | $169M | $179M | $191M | $206M | $175M | $188M | $117M | $130M | |
| Shares Outstanding | 22,475,000 | 22,407,000 | 22,407,000 | 22,386,000 | 22,386,000 | 22,300,000 | 22,300,000 | 22,254,465 | 22,254,102 | 1,262,638 | 1,248 |
Flux de trésorerie 9
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $284.0K | $307.0K | $310.0K | $317.0K | $317.0K | $296.0K | $262.0K | $265.0K | $263.0K | $247.0K | |
| Stock-based Comp | $3M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $911.0K | |
| Other Non-cash | · | $-3M | · | · | · | $-886.0K | · | · | · | · | · | |
| Operating Cash Flow | $-21M | $-15M | $-10M | $-10M | $-12M | $-15M | $-16M | $-13M | $-16M | $-16M | $-12M | |
| CapEx | $38.0K | $8.0K | $424.0K | $15.0K | $48.0K | $59.0K | $466.0K | $483.0K | $2M | $83.0K | $268.0K | |
| Investing Cash Flow | $23M | $15M | $13M | $10M | $11M | $3M | $2M | $22M | $-68M | $18M | $16M | |
| Financing Cash Flow | · | · | $24.0K | $0 | · | · | $113.0K | $-13.0K | $91M | $-924.0K | $-1M | |
| Net Change in Cash | $2M | $-385.0K | $3M | $283.0K | $-420.0K | $-11M | $-14M | $9M | $6M | $1M | $3M | |
| Free Cash Flow | · | $-15M | · | · | · | $-15M | · | · | · | $-16M | · |
Rentabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -18.7% | -8.2% | · | -8.1% | -8.5% | -10.2% | · | -18.9% | -18.0% | -26.4% | · | |
| ROE | -25.1% | -12.2% | · | -10.1% | -10.4% | 686.3% | · | -20.0% | -18.9% | 21.9% | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.5 | 9.9 | · | 10.1 | 14.1 | 22.1 | · | 17.0 | 20.4 | 10.5 | · | |
| Quick Ratio | 9.3 | 9.7 | · | 9.9 | 13.8 | 21.8 | · | 16.7 | 20.0 | 9.9 | · |
Valorisation (TTM) 8
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-67M | $-59M | · | $-62M | $-65M | $-65M | · | $-62M | $-58M | $-53M | · | |
| Market Cap | $56M | $25M | · | $28M | $23M | $34M | · | $77M | $86M | $18M | · | |
| P/E | -0.8 | -0.4 | · | -0.4 | -0.3 | -0.1 | · | -0.1 | -0.1 | -0.3 | · | |
| P/B | 0.9 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.5 | 0.5 | -0.1 | · | |
| P / Tangible Book | 0.9 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.5 | 0.5 | · | · | |
| P / Cash Flow | · | -1.6 | · | · | · | -2.3 | · | · | · | -1.1 | · | |
| P / FCF | · | -1.6 | · | · | · | -2.3 | · | · | · | -1.1 | · | |
| Earnings Yield | -119.2% | -239.1% | · | -225.2% | -289.1% | -959.6% | · | -705.8% | -879.3% | -302.9% | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Résultat net | $-58M | $-65M | $-49M |
| BPA dilué | $-2.60 | $-3.85 | $-40.65 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ratio de liquidité | 8.7 | 19.0 | — |
| Ratio de liquidité réduite | 8.6 | 18.7 | — |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Flux de trésorerie libre | $-47M | $-63M | — |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 45 déclarants · $37.6M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 16 (+9 vs T. préc.) | 8 (+2 vs T. préc.) | 8 (+2 vs T. préc.) | 10 (+2 vs T. préc.) | +7.4M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| ARCH Venture Management, LLC | $6 735 238 | 2 694 095 | 17,91% | Actions |
| TANG CAPITAL MANAGEMENT LLC | $6 399 688 | 2 559 875 | 17,02% | Actions |
| ADAR1 Capital Management, LLC | $4 920 540 | 1 968 216 | 13,08% | Actions |
| Nextech Invest Ltd. | $3 561 400 | 1 228 069 | 9,47% | Actions |
| FMR LLC | $3 332 450 | 1 332 980 | 8,86% | Actions |
| Cormorant Asset Management, LP | $2 500 000 | 1 000 000 | 6,65% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 537 308 | 614 923 | 4,09% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $1 390 583 | 556 233 | 3,70% | Actions |
| MILLENNIUM MANAGEMENT LLC | $1 196 598 | 478 639 | 3,18% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $1 178 925 | 471 570 | 3,13% | Actions |
| Alyeska Investment Group, L.P. | $750 000 | 300 000 | 1,99% | Actions |
| Affinity Asset Advisors, LLC | $625 000 | 250 000 | 1,66% | Actions |
| RBF Capital, LLC | $500 000 | 200 000 | 1,33% | Actions |
| Ensign Peak Advisors, Inc | $399 588 | 159 835 | 1,06% | Actions |
| Stonepine Capital Management, LLC | $386 488 | 154 595 | 1,03% | Actions |
| CITADEL ADVISORS LLC | $362 623 | 145 049 | 0,96% | Actions |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $320 000 | 128 000 | 0,85% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $240 132 | 96 053 | 0,64% | Actions |
| PRELUDE CAPITAL MANAGEMENT, LLC | $209 995 | 83 998 | 0,56% | Actions |
| Rangeley Capital, LLC | $185 000 | 74 000 | 0,49% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $162 840 | 65 136 | 0,43% | Actions |
| SUPERSTRING CAPITAL MANAGEMENT LP | $138 390 | 55 356 | 0,37% | Actions |
| JANE STREET GROUP, LLC | $114 675 | 45 870 | 0,30% | Actions |
| NORTHERN TRUST CORP | $87 060 | 34 824 | 0,23% | Actions |
| XTX Topco Ltd | $83 403 | 33 361 | 0,22% | Actions |
| Nuveen Asset Management, LLC | $62 417 | 21 523 | 0,17% | Actions |
| Qube Research & Technologies Ltd | $50 518 | 20 207 | 0,13% | Actions |
| China Universal Asset Management Co., Ltd. | $42 250 | 16 900 | 0,11% | Actions |
| STATE STREET CORP | $39 905 | 15 962 | 0,11% | Actions |
| MORGAN STANLEY | $32 500 | 13 000 | 0,09% | Actions |
| Caitong International Asset Management Co., Ltd | $26 108 | 10 443 | 0,07% | Actions |
| Pure Financial Advisors, LLC | $25 250 | 10 100 | 0,07% | Actions |
| BlackRock, Inc. | $10 223 | 4 089 | 0,03% | Actions |
| Tower Research Capital LLC (TRC) | $870 | 348 | 0,00% | Actions |
| VANGUARD GROUP INC | $515 | 429 | 0,00% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $440 | 176 | 0,00% | Actions |
| ACADIAN ASSET MANAGEMENT LLC | $365 | 146 757 | 0,00% | Actions |
| HRT FINANCIAL LP | $290 | 116 288 | 0,00% | Actions |
| GSA CAPITAL PARTNERS LLP | $181 | 72 353 | 0,00% | Actions |
| MERCER GLOBAL ADVISORS INC /ADV | $125 | 50 | 0,00% | Actions |
| JPMORGAN CHASE & CO | $25 | 10 | 0,00% | Actions |
| CWM, LLC | $9 | 8 | 0,00% | Actions |
| Financial Management Professionals, Inc. | $5 | 2 | 0,00% | Actions |
| UBS Group AG | $5 | 2 | 0,00% | Actions |
| SBI Securities Co., Ltd. | $5 | 2 | 0,00% | Actions |
Initiés de la société 14 initiés · 8 dirigeants · 7 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Zachary Hornby | President & CEO | 23 janvier 2026 A | — | 0 | 0 | $0 |
| Jami Rubin | Chief Financial Officer | 19 août 2024 A | — | 0 | 0 | $0 |
| Robert Doebele | Chief Medical Officer | 23 janvier 2026 A | — | 0 | 0 | $0 |
| Jessica Oien | Chief Legal Officer and Corporate Secretary | 23 janvier 2026 A | — | 0 | 0 | $0 |
| Christian Hassig | Chief Scientific Officer | 23 janvier 2026 A | — | 0 | 0 | $0 |
| David A Hinkle | Senior VP, Finance, Controller and Treasurer | 23 janvier 2026 A | — | 0 | 0 | $0 |
| Klaus W. Wagner | Chief Medical Officer | 19 août 2024 A | — | 0 | 0 | $0 |
| Neil Abdollahian | Chief Business Officer | 19 août 2024 A | — | 0 | 0 | $0 |
| James Christensen | Administrateur | 15 juin 2026 A | — | 0 | 0 | $0 |
| Nancy Whiting | Administrateur | 15 juin 2026 A | — | 0 | 0 | $0 |
| Jennifer Lew | Administrateur | 15 juin 2026 A | — | 0 | 0 | $0 |
| Jonathan E Lim | Administrateur | 15 juin 2026 A | 550 915 | 0 | 0 | $0 |
| Christine Brennan | Administrateur | 23 juin 2025 A | — | 0 | 0 | $0 |
| Kristina Burow | Administrateur | 23 juin 2025 A | 1 181 766 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 1 participation
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., ARCH Venture Fund X Overage, L.P., ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Partners X Overage, L.P., ARCH Venture Partners IX, LLC, ARCH Venture Partners X, LLC, Robert Nelsen, Keith Crandell, Clinton Bybee, Kristina Burow, Steven Gillis | 29 octobre 2024 | — | Dépôt initial | Investissement passif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 3 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.